Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 4990-4994

  Grimm, Michael C ^a,b   Newman, Rosie ^a,b   Hassim, Zeenath ^a,b   Cuan, Natalia ^a,b   Connor, Susan J ^a,b   Le, Yingying ^c   Wang, Ji Ming ^c   Oppenheim, Joost J ^c   Lloyd, Andrew R ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCL3; CHEMOKINE RECEPTOR CXCL4; CHEMOKINE RECEPTOR CXCL5; CHEMOKINE RECEPTOR CXCR4; G PROTEIN COUPLED RECEPTOR; NEUROTRANSMITTER; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CHEMOTAXIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VIVO STUDY; INFLAMMATION; INTERNALIZATION; LEUKOCYTE; LYMPHOCYTIC INFILTRATION; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

EID: 0242580114     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.4990     Document Type: Article

References (26)

1. Godaly, G., G. Bergsten, L. Hang, H. Fischer, B. Frendeus, A. C. Lundstedt, M. Samuelsson, P. Samuelsson, and C. Svanborg. 2001. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J. Leukocyte Biol. 69:899.
2. Lukacs, N. W., D. M. Prosser, M. Wiekowski, S. A. Lira, and D. N. Cook. 2001. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J. Exp. Med. 194:551.
3. + T cell accumulation in rheumatoid arthritis synovium. J. Immunol. 165:6590.
4. Grimm, M. C., S. K. O. Elsbury, P. Pavli, and W. F. Doe. 1996. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J. Leukocyte Biol. 59:804.
5. Papadakis, K. A., J. Prehn, S. T. Moreno, L. Cheng, E. A. Kouroumalis, R. Deem, T. Breaverman, P. D. Ponath, D. P. Andrew, P. H. R. Green, et al. 2001. CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease. Gastroenterology 121:246.
6. Moatti, D., S. Faure, F. Fumeron, M. E. W. Amara, P. Seknadji, D. H. McDermott, P. Debré, M. C. Aumont, P. M. Murphy, D. de Prost, and C. Combadičre. 2001. Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery disease. Blood 97:1925.
7. Murphy, P. M. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116.
8. Johnston, J. A., D. D. Taub, A. R. Lloyd, K. Conlon, J. J. Oppenheim, and D. J. Kelvin. 1994. Human T lymphocyte chemotaxis and adhesion induced by vasoactive intestinal peptide. J. Immunol. 153:1762.
9. Delgado, M., W. Sun, J. Leceta, and D. Ganea. 1999. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J. Immunol. 163:4213.
10. Delgado, M., J. Leceta, C. Abad, C. Martinez, D. Ganea, and R. P. Gomariz. 1999. Shedding of membrane-bound CD14 from lipopolysaccharide-stimulated macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide. J. Neuroimmunol. 99:61.
11. Delgado, M., and D. Ganea. 2001. Is vasoactive intestinal peptide a type 2 cytokine? J. Immunol. 166:2907.
12. Ottaway, C. A. 1991. Neuroimmunomodulation in the intestinal mucosa. Gastroenterol. Clin. North Am. 20:511.
13. Metwali, A., A. M. Blum, L. Ferraris, J. S. Klein, C. Fiocchi, and J. V. Weinstock. 1994. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J. Neuroimmunol. 52:69.
14. Reubi, J. C., U. Horisberger, A. Kappeler, and J. A. Laissue. 1998. Localization of receptors for vasoactive intestinal peptide, somatostatin, and substance P in distinct compartments of human lymphoid organs. Blood 92:191.
15. Grimm, M. C., A. Ben-Baruch, D. D. Taub, O. M. Z. Howard, J. H. Resau, J. M. Wang, H. Ali, R. Richardson, R. Snyderman, and J. J. Oppenheim. 1998. Opiates trans-deactivate chemokine receptors: δ and μ opiate receptor-mediated heterologous desensitization. J. Exp. Med. 188:317.
16. Badolato, R., J. A. Johnston, J. M. Wang, D. McVicar, L. L. Xu, J. J. Oppenheim, and D. J. Kelvin. 1995. Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 155:4004.
17. Shen, W., B. Li, M. A. Wetzel, T. J. Rogers, E. E. Henderson, S. B. Su, W. Gong, Y. Le, R. Sargeant, D. S. Dimitrov, J. J. Oppenheim, and J. M. Wang. 2000. Downregulation of the chemokine receptor CCR5 by activation of chemotactic formyl peptide receptor in human monocytes. Blood 96:2887.
18. Tedla, N., H.-W. Wang, H. P. McNeil, N. Di Girolamo, T. Hampartzoumian, D. Wakefield, and A. R. Lloyd. 1998. Regulation of T lymphocyte trafficking into lymph nodes during an immune response by the chemokines, MIP-1α and MIP-1β. J. Immunol. 161:5663.
19. Lara-Marquez, M., M. O'Dorisio, T. O'Dorisio, M. Shah, and B. Karacay. 2001. Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells. J. Immunol. 166:2522.
20. Yang, W., D. Wang, and A. Richmond. 1999. Role of clathrin-mediated endocytosis in CXCR2 sequestration, resensitization, and signal transduction. J. Biol. Chem. 274:11328.
21. Ben-Baruch, A., M. Grimm, K. Bengali, G. A. Evans, O. Chertov, J. M. Wang, O. M. Z. Howard, N. Mukaida, K. Matsushima, and J. J. Oppenheim. 1997. The differential ability of IL-8 and NAP-2 to induce attenuation of chemotaxis is mediated by their divergent capabilities to phosphorylate CXCR2 (IL-8RB). J. Immunol. 158:5927.
22. Oppermann, M., M. Mack, A. E. Proudfoot, and H. Olbrich. 1999. Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J. Biol. Chem. 274:8875.
23. Ali, H., R. M. Richardson, E. D. Tomhave, J. R. Didsbury, and R. Snyderman. 1993. Differences in phosphorylation of formylpeptide and C5a chemoattractant receptors correlate with differences in desensitization. J. Biol. Chem. 268:24247.
24. Carolan, E. J., and T. B. Casale. 1993. Effects of neuropeptides on neutrophil migration through noncellular and endothelial barriers. J. Allergy Clin. Immunol. 92:589.
25. Pedrera, C., M. Lucas, L. Bellido, and M. A. Lopez-Gonzalez. 1994. Receptor-independent mechanisms are involved in the priming of neutrophil's oxidase by vasoactive intestinal peptide. Regul. Pept. 54:505.
26. Delgado, M., C. Abad, C. Martinez, J. Leceta, and R. P. Gomariz. 2001. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med. 7:563.